Listen: A CRISPR milestone, algorithms amok, & biotech mixology
This week on "The Readout LOUD" podcast: A CRISPR milestone, algorithms amok, and biotech mixology.
Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.
What's Your Reaction?
